SCHEMBL8957388

SCHEMBL8957388

O=[N+]([O-])OCCC(c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.47
PTGS1 P23219 1/20 0.45
PTGS2 P35354 1/20 0.45
HRH1 P35367 6/20 0.42
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
HTR2A P28223 5/20 0.39
ESR2 Q92731 2/20 0.38
NPC1 O15118 1/20 0.38
ADAM17 P78536 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
CCR2 P41597 1/20 0.37
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8957372 0.80 GSR (0.50) GSRPTGS1PTGS2CNR1CNR2
SCHEMBL9874449 0.78 PTGS1 (0.49) GSRPTGS1PTGS2HRH1HTR2A
SCHEMBL18435582 0.78 SLC6A3 (0.40) GSRPTGS1PTGS2CNR1ESR2
SCHEMBL9872237 0.77 GSR (0.47) GSRPTGS1PTGS2ESR2NPC1
SCHEMBL8957414 0.77 CPA1 (0.46) GSRPTGS1PTGS2
SCHEMBL242578 0.73 HRH1 (0.50) HRH1CNR1CNR2HTR2AALDH1A1
SCHEMBL1491311 0.72 CA1 (0.46) PTGS1PTGS2ESR2NPC1
SCHEMBL29280865 0.72 HRH1 (0.54) HRH1CNR1CNR2HTR2AALDH1A1
SCHEMBL2421009 0.72 HRH1 (0.54) HRH1HTR2AALDH1A1HTTMTNR1A
SCHEMBL14000549 0.72 SCN4A (0.52) GSRPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
US-5049694-A Cardiovascular disorders CEDONA PHARMACEUTICALS B.V. (NL) 1991-09-17 US claimed
US-5049694-A Cardiovascular disorders CEDONA PHARMACEUTICALS B.V. (NL) 1991-09-17 US disclosed
EP-0359335-A2 Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance CEDONA PHARMACEUTICALS B.V. (NL) 1990-03-21 EP disclosed